Journal Watch · Nature Genetics · 2026
Single-allele nanoscale mapping of regulatory variants.
We showed that SESN3 regulates mammalian target of rapamycin by sensing tryptophan and demonstrated its role in autoimmunity using mouse models.
TL;DR
We showed that SESN3 regulates mammalian target of rapamycin by sensing tryptophan and demonstrated its role in autoimmunity using mouse models.
Key findings
- With this approach, we investigated 405 cis-regulatory elements linked to immune-mediated inflammatory disease in CD4<sup>+</sup> T cells.
- We uncovered a previously undescribed gain-of-function mechanism, which increases risk of autoimmunity through creation of a neo-CTCF motif that blocks super-enhancer contacts with the SESN3 promoter.
- We showed that SESN3 regulates mammalian target of rapamycin by sensing tryptophan and demonstrated its role in autoimmunity using mouse models.
What they did
This can identify changes in nanoscale chromatin architecture and link variants in cis-regulatory elements to target genes. Furthermore, MCCv can phase other heterozygous variants within a locus to link regulatory variants to allelically imbalanced gene expression and directly read out variant effects on chromatin interactions after genome editing.
Full abstract (original)
Background: Millions of genetic variants are linked to human disease but identifying underlying mechanisms is challenging because most variants are noncausal and lie within the noncoding genome. We developed a Micro Capture-C variant-to-function platform (MCCv) based on analysis of single-allele chromatin structure.
What they did: This can identify changes in nanoscale chromatin architecture and link variants in cis-regulatory elements to target genes. Furthermore, MCCv can phase other heterozygous variants within a locus to link regulatory variants to allelically imbalanced gene expression and directly read out variant effects on chromatin interactions after genome editing.
Results & conclusions: With this approach, we investigated 405 cis-regulatory elements linked to immune-mediated inflammatory disease in CD4<sup>+</sup> T cells. We uncovered a previously undescribed gain-of-function mechanism, which increases risk of autoimmunity through creation of a neo-CTCF motif that blocks super-enhancer contacts with the SESN3 promoter. We showed that SESN3 regulates mammalian target of rapamycin by sensing tryptophan and demonstrated its role in autoimmunity using mouse models.
Abstract © the authors / Nature Genetics (2026). Reproduced here for discussion and indexing, with attribution. Read the original at https://doi.org/10.1038/s41588-026-02776-8 · PubMed 42827183.
Why it matters for pharma & biotech
- Relevant to Biology & Life Sciences teams tracking Nature Genetics for new targets, mechanisms and biomarkers.
- As earlier-stage work, its near-term value is target validation and assay design rather than clinical decisions.
- For searchers: the full abstract is reproduced below, so you can judge relevance before opening the publisher page.
Limitations & what to check in the full text
- This brief is based on the published abstract only. Effect sizes, subgroup results and safety detail in the full text may qualify the headline findings.
- The work is preclinical. Results in animal or cell models frequently do not translate directly to human efficacy or safety.
- The abstract reports its conclusions qualitatively, without headline effect sizes — read the full text before citing a magnitude.
Frequently asked questions
What did this Nature Genetics study find?
We showed that SESN3 regulates mammalian target of rapamycin by sensing tryptophan and demonstrated its role in autoimmunity using mouse models.
What type of study is this?
It is a preclinical (animal / model) study, published in Nature Genetics in 2026. This can identify changes in nanoscale chromatin architecture and link variants in cis-regulatory elements to target genes.
Where can I read the original paper?
The original is at the publisher via DOI 10.1038/s41588-026-02776-8. PubMed ID: 42827183. BioStudioAI reproduces the abstract for discussion and links to the source.
This brief: BioStudioAI Journal Watch, 29 October 2026. https://biostudioai.com/blog/papers/single-allele-nanoscale-mapping-of-regulatory-variants-027768/
Reading papers is step one. Analysing the data is the work.
BioStudioAI turns raw lab files into QC'd results, statistics, figures, reports and slides — hosted on your servers, every number computed, nothing typed.
Open BioStudioAI More guides